Phase II Trial of 131-Iodine Tositumomab with High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B Cell Lymphoma
作者单位：Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United[1]Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE, United States[2]Department of Radiology, Section of Nuclear Medicine, University of Nebraska Medical Center, Omaha[3]Department of Internal Medicine, Division of Hematology/Oncology, University of Nebraska Medical[4]
换一批
